<DOC>
	<DOCNO>NCT01619982</DOCNO>
	<brief_summary>The investigator hope learn 1 ) addition prophylaxis vancomycin decrease rate cefazolin non-susceptible SSI 's , high risk population 2 ) develop well understand vancomycin cefazolin pharmacokinetics child undergo cardiopulmonary bypass 3 ) ass barrier vancomycin dose peri-operatively 4 ) assess side effect risk associate peri-operative vancomycin administration . This allow u improve patient care well understand benefit risk peri-operative vancomycin administration potentially decrease cefazolin-resistant surgical site infection . In addition , study give u opportunity evaluate cefazolin vancomycin pharmacokinetics child CPB . The investigator take blood sample 20 patient . In 10 patient investigator Cefazolin pK analysis 10 investigator pK Vancomycin analysis . For remainder 292 patient , prospective chart review do determine incidence SSI 's . This data compare 936 control receive Cefazolin pre-operatively prophylaxis SSI 's .</brief_summary>
	<brief_title>Pre-operative Prophylaxis With Vancomycin Cefazolin Pediatric Cardiovascular Surgery Patients</brief_title>
	<detailed_description>With 100 % compliance surgical infection prevention ( SIP ) bundle , risk surgical site infection ( SSIs ) decrease considerably , still great baseline rate best comparison hospital ( 2.5 % ) . Recent analysis SSI 's cardiovascular surgery patient identify half cause cefazolin resistant gram positive bacteria ( methicillin resistant coagulase negative staphylococci- MRSE , methicillin resistant Staphylococcus aureus- MRSA ) . Cefazolin routinely give pre-operatively surgical prophylaxis patient undergo cardiovascular surgery . Vancomycin routinely recommend prophylaxis due concern develop vancomycin resistance , however patient MRSE MRSA SSIs end need additional surgery remove replace infected hardware graft and/or additional week month intravenous vancomycin therapy . This result significant morbidity child cost institution . Several publish guideline suggest use pre-operative prophylaxis vancomycin ( alone conjunction cefazolin ) instance patient may high risk infection MRSE MRSA . The purpose study determine whether addition vancomycin standard pre-operative prophylaxis cefazolin select high risk subject along full SIP bundle decrease incidence cefazolin-resistant SSI 's .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>1 . Patient le equal 1 year age undergo cardiovascular surgery require CPB patient 18 year age undergoing procedure involve aortic valve aorta 2 . Patients positive MRSA screen history MRSA infection undergo cardiac surgery 1 . Patients know hypersensitivity vancomycin cephalosporins 2 . Patients renal insufficiency 3 . Patients receive vancomycin cephalosporin 48 hour prior day surgery 4 . Patients whose surgery due infectionrelated diagnosis endocarditis 5 . Patients whose parent wish receive vancomycin prophylaxis 6 . Neonates bear less 38 week gestational age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>